Skip to content

Clinical trials

Phase 3 Immune System Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Immune System Diseases Phase: Phase 3 Clear all

61 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20091
20102
20112
20122
20135
20141
20152
20162
20172
20185
20201
20212
20224
20236
20241
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed34
Terminated7
Recruiting6
Active, not recruiting6
Unknown status3
Withdrawn3
Enrolling by invitation2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Center for Research Resources (NCRR)7
Pfizer4
AstraZeneca3
Eli Lilly and Company3
Ellodi Pharmaceuticals, LP3
Organon and Co3
Viatris Innovation GmbH3
Bristol-Myers Squibb2
Merz North America, Inc.2
National Institute of Allergy and Infectious Diseases (NIAID)2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Immune System Diseases61
Autoimmune Diseases19
Hypersensitivity13
Communicable Diseases12
Rare Diseases12
Connective Tissue Diseases11
Hypersensitivity, Immediate11
Lupus Erythematosus, Systemic11
Skin Diseases9
Dermatitis, Atopic8

Trials

Showing 26 to 50 of 61. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.